Apceth commences Phase I/II peripheral arterial occlusive disease study
Apceth has initiated the first Phase I/II clinical study of its somatic cell therapy for peripheral arterial occlusive disease after angioplasty. The study, being conducted in cooperation with Isar Medizin Zentrum in Munich, Germany, aims to evaluate the tolerability and efficacy of somatic cell therapeutics for the treatment of the disease. The open and randomised study, will have two...
0 Comments 0 Shares
Sponsored